EpiPen Maker Says Securities Fraud Allegations Don't Add Up
EpiPen maker Mylan NV asked a New York federal judge on Tuesday to throw out a shareholder suit that accuses it of securities fraud, saying the investors' references to other investigations and...To view the full article, register now.
Already a subscriber? Click here to view full article